Your session is about to expire
← Back to Search
Behavioural Intervention
Breathing Interventions for SUDEP Prevention in Epilepsy (BreatheS Trial)
N/A
Recruiting
Led By Nuria L Lecumberri, MD,PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (before breathing task), at the time of the breathing task(about 8 minutes after start of baseline)
Awards & highlights
BreatheS Trial Summary
This trial aims to map brain networks that control breathing & find ways to stop seizures from affecting it.
Who is the study for?
This trial is for individuals with intractable focal epilepsy who are admitted to the Epilepsy Monitoring Unit at Memorial Hermann-Texas Medical Center for specific brain monitoring procedures. It's not suitable for pregnant women, prisoners, or those with respiratory, cardiac, or cerebrovascular diseases.Check my eligibility
What is being tested?
The study aims to map out brain networks that control breathing and find ways to stimulate certain brain areas to prevent breathing failure during seizures using tasks and mapping techniques.See study design
What are the potential side effects?
Potential side effects may include discomfort from the breathing tasks or adverse reactions from the brain stimulation, such as headaches or temporary changes in mood or cognition.
BreatheS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (before stimulation), at the time of stimulation (about 8 minutes after start of baseline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (before stimulation), at the time of stimulation (about 8 minutes after start of baseline)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Saturation of peripheral oxygen (SpO2) during stimulation as assessed by the pulse oximetry
Change in end tidal carbon dioxide (CO2) during stimulation
Change in percentage of breathing node size as assessed by electroencephalogram (EEG) signal
+3 moreSecondary outcome measures
Quantification of the breathing changes as assessed by the change in breathing depth
Quantification of the breathing changes as assessed by the change in breathing minute ventilation (MV)
Quantification of the breathing changes as assessed by the change in breathing rate
BreatheS Trial Design
1Treatment groups
Experimental Treatment
Group I: Breathing tasks and Brain mapping with stimulationExperimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,860 Total Patients Enrolled
7 Trials studying Epilepsy
393 Patients Enrolled for Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,489 Total Patients Enrolled
78 Trials studying Epilepsy
24,953 Patients Enrolled for Epilepsy
Nuria L Lecumberri, MD,PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of lung, heart, or stroke-related conditions.I am admitted to the EMU for a specific epilepsy study.I have been diagnosed with hard-to-treat focal epilepsy.
Research Study Groups:
This trial has the following groups:- Group 1: Breathing tasks and Brain mapping with stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any new participants being recruited for this research project?
"Data on clinicaltrials.gov reveals that this trial has not been actively recruiting since July 31st 2023, and there are currently no plans to re-open recruitment for the study. Fortunately, 30 other trials have remained open with participants still being welcomed in."
Answered by AI
Share this study with friends
Copy Link
Messenger